NOT-MD-23-012: Notice of Correction to Application Project Period in RFA-MD-23-003, "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44

Notice of Correction to Application Project Period in RFA-MD-23-003, "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)"

Notice Number:

NOT-MD-23-012

Key Dates

Release Date:

July 24, 2023

Related Announcements

January 30, 2023 - "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional). See NOFO RFA-MD-23-003.

Issued by

National Institute on Minority Health and Health Disparities (NIMHD)

Purpose

The purpose of this Notice is to correct the project period for Phase I for RFA-MD-23-003, Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

The following section of RFA-MD-23-003 has been corrected:

Part 2. Full Text of Announcement, Section II. Award Information

Currently reads:

Award Project Period

According to statutory guidelines, award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.

Corrected to read (bold italics):

Award Project Period

According to statutory guidelines, award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

LCDR Michael Banyas, USPHS, MPA
National Insitute on Minority Health and Health Disparities (NIMHD)
Phone: 240-619-9483
Email: nimhdsbirsttr@mail.nih.gov